Testing Latest Version of NidekRS3000Adv

Glaucoma Clinical Trial

Official title:

Testing Latest Version of NidekRS3000Adv

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03318705
• Other study ID #: NIDEKRS3000ADV
• Status: Completed
• Start date: February 1, 2018
• Est. completion date: March 28, 2018

Study information

• Verified date: July 2018
• Source: Doheny Image Reading Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: March 28, 2018
• Est. primary completion date: March 28, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Healthy participants

• 18 years old or older

Exclusion Criteria:

• Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging

• subjects who are unable to maintain retinal fixation on a specified target

• subjects unable to achieve sufficient pupil dilation and alignment stability for imaging to take place

• subjects with media opacity which preclude high quality imaging will be excluded.

• vulnerable subjects

• subjects under 18

• pregnant subjects

• economically and educationally disadvantaged subjects

• decision impaired subjects

• homeless subjects

Related Conditions & MeSH terms

• Glaucoma

Intervention

Device:
• RS3000Adv
Nidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants

Locations

Country	Name	City	State
United States	Doheny Eye Centers UCLA	Pasadena	California

Sponsors (1)

Lead Sponsor	Collaborator
Doheny Image Reading Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ocular vascularization	Nidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants	1 year